SPONSORED ADS
Teva Pharmaceutical Inds Ltd
Teva Pharmaceutical Inds Ltd
Holdings as of 2025-09-30Filed 2025-11-14Updated 2026-10-22
View original evidence ↗Viewing holdings for 2025 Q3. View latest quarter →
Investors holding2
New positions0
Increased1
Decreased1
Exited0
Holdings by investor
↓ CSV↔ Scroll table
| Investor | Portfolio weight | Shares | Shares Δ | Change | Filed | Evidence |
|---|---|---|---|---|---|---|
| Stanley DruckenmillerDuquesne Family Office | 8.53%+1.7 pp | 16,593,935 | +3.9% | Increased | 2025-11-14 | SEC filing |
| Viking GlobalViking Global | 0.13%-0.4 pp | 2,532,119 | -78.3% | Decreased | 2025-11-14 | SEC filing |
Ownership over time
All 20 quarters
| Quarter | Investors holding |
|---|---|
| 2026 Q2 | 1 |
| 2026 Q1 | 1 |
| 2025 Q4 | 1 |
| 2025 Q3 | 2 |
| 2025 Q2 | 2 |
| 2025 Q1 | 2 |
| 2024 Q4 | 2 |
| 2024 Q3 | 2 |
| 2024 Q2 | 0 |
| 2024 Q1 | 0 |
| 2023 Q4 | 0 |
| 2023 Q3 | 0 |
| 2023 Q2 | 0 |
| 2023 Q1 | 0 |
| 2022 Q4 | 0 |
| 2022 Q3 | 0 |
| 2022 Q2 | 0 |
| 2022 Q1 | 0 |
| 2021 Q4 | 0 |
| 2021 Q3 | 1 |
Original sources
Public commentary is shown only when a dated, verified original is available.
Duquesne Family OfficeOfficial SEC filing
Viking GlobalOfficial SEC filing
Advanced · SEC data & downloads
CUSIP 881624209 · SPONSORED ADS
Original information table · XML/data
Original information table · XML/data
Duquesne Family Office · 13F-HR · SEC filing · TXT
Viking Global · 13F-HR · SEC filing · TXT
Download full history CSV · all candidate groups